198 related articles for article (PubMed ID: 20588063)
1. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
Dunér F; Lindström K; Hultenby K; Hulkko J; Patrakka J; Tryggvason K; Haraldsson B; Wernerson A; Pettersson E
Nephron Exp Nephrol; 2010; 116(2):e42-52. PubMed ID: 20588063
[TBL] [Abstract][Full Text] [Related]
2. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between podocyte molecule's distribution and expression, foot process morphology and proteinuria].
Guan N; Deng JH; Ding J; Zhang JJ; Yang JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):139-44. PubMed ID: 15100730
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
6. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
7. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
9. Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome.
Smoyer WE; Mundel P; Gupta A; Welsh MJ
Am J Physiol; 1997 Jul; 273(1 Pt 2):F150-7. PubMed ID: 9249603
[TBL] [Abstract][Full Text] [Related]
10. Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis.
Hosoyamada M; Yan K; Nishibori Y; Takiue Y; Kudo A; Kawakami H; Shibasaki T; Endou H
J Pharmacol Sci; 2005 Feb; 97(2):234-41. PubMed ID: 15684566
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
Olson JL; Rennke HG; Venkatachalam MA
Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
Inokuchi S; Shirato I; Kobayashi N; Koide H; Tomino Y; Sakai T
Kidney Int; 1996 Oct; 50(4):1278-87. PubMed ID: 8887289
[TBL] [Abstract][Full Text] [Related]
13. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
14. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
[TBL] [Abstract][Full Text] [Related]
15. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
16. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
Kojima K; Matsui K; Nagase M
Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
[TBL] [Abstract][Full Text] [Related]
17. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
[TBL] [Abstract][Full Text] [Related]
20. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
